What is Artiva Biotherapeutics, Inc.'s investing cash flow?

Artiva Biotherapeutics, Inc. (ARTV) reported investing cash flow of $15.32M in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s investing cash flow changed year-over-year?

Artiva Biotherapeutics, Inc.'s investing cash flow increased by 53.6% year-over-year, from $9.97M to $15.32M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Artiva Biotherapeutics, Inc. ARTV Investing Cash Flow

Investing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$131M+73.7%

Gilead SciencesGILD

$1.77B+527%

Kyverna Therapeutics, Inc.KYTX

-$50.2M-1,000%

Allogene TherapeuticsALLO

-$29.59M-579%

Immix Biopharma, Inc.IMMX

-$4.8M-6,990%

ImmunityBio, Inc.IBRX

-$31.65M-867%

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s investing cash flow?: Artiva Biotherapeutics, Inc. (ARTV) reported investing cash flow of $15.32M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s investing cash flow changed year-over-year?: Artiva Biotherapeutics, Inc.'s investing cash flow increased by 53.6% year-over-year, from $9.97M to $15.32M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.